Literature DB >> 20810215

Effects of doxycycline on the endosymbiont Wolbachia in Dirofilaria immitis (Leidy, 1856)--naturally infected dogs.

Maria Ines Doria Rossi1, Jonimar Paiva, Alexandre Bendas, Flavya Mendes-de-Almeida, Fabiana Knackfuss, Marcia Miranda, Jorge Guerrero, Octavio Fernandes, Norma Labarthe.   

Abstract

Dirofilaria immitis carries intracellular endosymbiotic bacteria of the genus Wolbachia, known to be vital for the worms and sensitive to tetracycline antibiotics. With the purpose of studying the interaction between D. immitis and the endosymbiont Wolbachia sp., heartworm naturally infected microfilaremic or antigenemic dogs were treated with doxycycline (10mg/kg/day of the drug in three cycles of 21 days each, with 6-month intervals). Blood samples were collected on days 0, 7 and 21 of each treatment as well as on day 111 after the beginning of each cycle. A final sample was collected on day 723 from the beginning of the first treatment. The samples were examined for the presence and number of microfilariae and the presence of antigen as well as the presences of D. immitis and Wolbachia sp. DNA using PCR (polymerase chain reaction). With this approach, an evaluation of the effect of doxycycline on antigenemia and on the presence of Wolbachia sp. DNA in dogs with heartworm infection was possible. Doxycycline treatment did not alter the detection of adult parasite antigens with the exception of two animals, though the number of animals carrying Wolbachia sp. DNA decreased, despite the presence of the microfilariae. The effect of the antibiotic therapy on the worms may have interfered with the transmission of heartworm disease because the population of microfilariae and the number of microfilaremic dogs were reduced and the microfilariae positive samples that were found did not test positive for Wolbachia sp. in many cases. These findings suggest that in areas were doxycycline is extensively used D. immitis transmission may be impaired by the reduction on the number of microfilariae and on the endosymbiotic bacteria in the larvae turning them incapable of completing development once they infected a new host.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810215     DOI: 10.1016/j.vetpar.2010.07.019

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

Review 1.  Dirofilaria immitis and Wolbachia pipientis: a thorough investigation of the symbiosis responsible for canine heartworm disease.

Authors:  Jake McHaffie
Journal:  Parasitol Res       Date:  2011-09-16       Impact factor: 2.289

Review 2.  Human and animal dirofilariasis: the emergence of a zoonotic mosaic.

Authors:  Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Variation in Tolerance to Parasites Affects Vectorial Capacity of Natural Asian Tiger Mosquito Populations.

Authors:  Guha Dharmarajan; Kathryne D Walker; Tovi Lehmann
Journal:  Curr Biol       Date:  2019-10-31       Impact factor: 10.834

4.  Delayed larval development in Anopheles mosquitoes deprived of Asaia bacterial symbionts.

Authors:  Bessem Chouaia; Paolo Rossi; Sara Epis; Michela Mosca; Irene Ricci; Claudia Damiani; Ulisse Ulissi; Elena Crotti; Daniele Daffonchio; Claudio Bandi; Guido Favia
Journal:  BMC Microbiol       Date:  2012-01-18       Impact factor: 3.605

5.  Detection of Canine Vector-Borne Filariasis and Their Wolbachia Endosymbionts in French Guiana.

Authors:  Younes Laidoudi; Jean-Lou Marie; Djamel Tahir; Stéphanie Watier-Grillot; Oleg Mediannikov; Bernard Davoust
Journal:  Microorganisms       Date:  2020-05-21

6.  Clinical and blood count findings in dogs naturally infected with Dirofilaria immitis.

Authors:  Alexandre José Rodrigues Bendas; Bruno Alberigi; Suzane Galardo; Norma Labarthe; Flavya Mendes-de-Almeida
Journal:  Braz J Vet Med       Date:  2022-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.